These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 29707035)
1. Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial. Zhao S; Tang Y; Cai H; Liu W; Zhang L; Chen D; Chen B Evid Based Complement Alternat Med; 2018; 2018():8485472. PubMed ID: 29707035 [TBL] [Abstract][Full Text] [Related]
2. Effect of Danhong Injection Combined with Naoxintong Tablets on Prognosis and Inflammatory Factor Expression in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention. Lv Y; Pan Y; Gao Y; Lu J; Li Y; Bai J; Zhai J Acta Cardiol Sin; 2015 Jul; 31(4):301-7. PubMed ID: 27122886 [TBL] [Abstract][Full Text] [Related]
3. Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis. Li Y; Li D; Wang W; Li X; Li P; Zhang Y; Lin Q; Li Y Front Cardiovasc Med; 2022; 9():1029387. PubMed ID: 36479564 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of Danhong Injection combined with Naoxintong Capsule on cerebral ischemia-reperfusion injury in rats. Wan J; Wan H; Yang R; Wan H; Yang J; He Y; Zhou H J Ethnopharmacol; 2018 Jan; 211():348-357. PubMed ID: 28986333 [TBL] [Abstract][Full Text] [Related]
5. [Effect of danhong injection on ET-1, sP-sel, and hs-CRP in patients with acute coronary syndrome undergoing percutaneous coronary intervention]. Zhao PX; Jiang S Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):11-4. PubMed ID: 21434335 [TBL] [Abstract][Full Text] [Related]
6. Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial. Shen Z; Chen T; Deng B; Fan M; Hua J; Zhang M; Wang X J Altern Complement Med; 2020 Nov; 26(11):1055-1063. PubMed ID: 32716206 [No Abstract] [Full Text] [Related]
7. The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. Zou JB; Zhang XF; Wang J; Wang F; Cheng JX; Yang FY; Song X; Wang Y; Liang YL; Shi YJ Front Pharmacol; 2018; 9():550. PubMed ID: 29915535 [No Abstract] [Full Text] [Related]
8. Effect of Danhong Injection () on Improving Coronary Microcirculation Injury after Percutaneous Coronary Intervention. Liu QR; Liu HX; Xing WL; Zhou Q; Zhang HL; Zhang HT; Song GY; Wu YJ Chin J Integr Med; 2021 Jun; 27(6):455-460. PubMed ID: 33433847 [TBL] [Abstract][Full Text] [Related]
9. [Effect of tongxinluo capsule on platelet activities and vascular endothelial functions as well as prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention]. Chen ZQ; Hong L; Wang H Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):487-91. PubMed ID: 21608219 [TBL] [Abstract][Full Text] [Related]
10. [Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention]. Chen ZQ; Hong L; Wang H; Yin QL Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr; 36(4):415-20. PubMed ID: 27323611 [TBL] [Abstract][Full Text] [Related]
11. [Effect of danhong injection on platelet activation and inflammatory factors in patients of acute coronary syndrome after intervention therapy]. Chen ZQ; Hong L; Wang H Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Aug; 29(8):692-4. PubMed ID: 19848198 [TBL] [Abstract][Full Text] [Related]
12. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients. Shang QH; Xu H; Lu XY; Wen C; Shi DZ; Chen KJ Chin J Integr Med; 2011 Sep; 17(9):669-74. PubMed ID: 21910067 [TBL] [Abstract][Full Text] [Related]
13. [Clinical comprehensive evaluation of Naoxintong Capsules in treatment of cerebral infarction with Qi deficiency and blood stasis syndrome and coronary heart disease angina pectoris]. Geng HJ; Xie YM; Wang ZF Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6087-6095. PubMed ID: 34951236 [TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH; Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056 [TBL] [Abstract][Full Text] [Related]
15. Effects of Danhong Injection () on Peri-Procedural Myocardial Injury and Microcirculatory Resistance in Patients with Unstable Angina Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study. Xing WL; Wu YJ; Liu HX; Liu QR; Zhou Q; Li AY; Zhang ZH; Li X Chin J Integr Med; 2021 Nov; 27(11):846-853. PubMed ID: 34263442 [TBL] [Abstract][Full Text] [Related]
16. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial. Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159 [TBL] [Abstract][Full Text] [Related]
17. [Myocardial protective effect of Danhong Injection evaluated by velocity vector imaging in patients undergoing percutaneous coronary intervention]. Dong J; Chen Y; Zhi G; Liu H; Wang J; Tian F; Zhou Y; Chen J Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(30):2346-9. PubMed ID: 25399975 [TBL] [Abstract][Full Text] [Related]
18. Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial. Guo M; Wang P; Du J; Fu C; Yang Q; Gao Z; Zhu M; Lv S; Deng Y; Li T; Shi D; Working Group FTX Pharmacol Res; 2020 Aug; 158():104883. PubMed ID: 32446979 [TBL] [Abstract][Full Text] [Related]
19. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial. Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study. Wu Y; Fu X; Feng Q; Gu X; Hao G; Fan W; Jiang Y BMC Cardiovasc Disord; 2020 Jun; 20(1):308. PubMed ID: 32590944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]